Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01206933 · ClinicalTrials.gov registry record
The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System
A clinical trial, sponsored by George Washington University.
- Completed
- Registry status
- 20
- Enrollment target
NCT01206933 is a clinical trial that has completed, run by George Washington University. The registered enrollment target is 20 participants.
The verdict
NCT01206933 has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Investigators in the Division of Infectious Diseases and the Departments of Biochemistry and Molecular Biology of The George Washington University Medical Center are carrying out a research study to determine why patients with Human Immunodeficiency Virus (HIV) and Hepatitis C virus (HCV) co-infection (HIV/HCV) have a more rapid and progressive course of HCV infection, leading to fatty infiltration of the liver and cirrhosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-07 |
| Est. Completion | 2015-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01206933
The ClinicalTrials.gov registry entry for NCT01206933 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01206933 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01206933 about?
NCT01206933 is a clinical study titled "The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model System". Investigators in the Division of Infectious Diseases and the Departments of Biochemistry and Molecular Biology of The George Washington University Medical Center are carrying out a research study to determine why patients with Human Immunodeficiency Virus (HIV) and Hepatitis C virus (HCV) co-infecti...
What is the current status of trial NCT01206933?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2010-07. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT01206933?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.